Solventum Corporation (SOLV) Stock Score, Valuation & Financial Research
Solventum Corporation is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 45/100.
Quick answer for SOLV
Solventum Corporation currently has a Wall Street Score of 45/100. The stored market price is $87.45. Its financial score is 60/100. Its valuation score is 27/100. These figures are a research snapshot, not a buy or sell recommendation.
What Solventum Corporation does
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like
SOLV financial snapshot
- Wall Street Score:
- 45/100
- Current price:
- $87.45
- Market capitalization:
- $15.14B
- Revenue:
- $8.26B
- Net income:
- $1.43B
- Free cash flow:
- $-10.0M
- Cash:
- $561.0M
- Total debt:
- $5.08B
- EPS:
- 8.94
- P/E ratio:
- 9.8x
- Financial score:
- 60/100
- Valuation score:
- 27/100
- Revenue score:
- 24/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-10.0M, showing cash burn in the current stored period.
- The balance sheet shows $561.0M of cash versus $5.08B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 27/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 60/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SOLV
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.